Long‐term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
Eustachio Nettis, Gabriella Fabbrocini, Michela Ortoncelli, Giovanni Pellacani, Giuseppe Argenziano, Elisabetta Di Leo, Cataldo Patruno, Luca Stingeni, Caterina Foti, Franco Rongioletti, Luigi Macchia, Simona Tavecchio, Maddalena Napolitano, Simone Ribero, Laura Bonzano, Giulia Calabrese, Danilo Di Bona, Steven Paul Nisticò, Katharina Hansel, Paolo Romita, Viviana Piras, Monica Carbonara, Aikaterini Detoraki, Silvia Mariel Ferrucci
Abstract
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
DupilumabAtopic dermatitisTerm (time)MedicineContent (measure theory)DermatologyMathematicsQuantum mechanicsPhysicsMathematical analysisDermatology and Skin DiseasesAllergic Rhinitis and SensitizationAsthma and respiratory diseases